Literature DB >> 7585651

Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.

J I Risinger1, A Umar, J C Boyer, A C Evans, A Berchuck, T A Kunkel, J C Barrett.   

Abstract

We have examined a panel of gynecological sarcomas for microsatellite instability. The genomic DNA from 11 of 44 sarcomas contained somatic alterations in the lengths of one or more di-, tri-, tetra-, or pentanucleotide microsatellite sequence markers, and 6 of these cases had alterations in two or more markers. In addition, di-, tri-, and tetranucleotide microsatellites were found to be highly unstable in single cell clones of two cell lines derived from a uterine mixed mesodermal tumor. Since such instability is characteristic of cells defective in postreplication mismatch repair, we examined mismatch repair activity in extracts made from these lines. Both extracts were repair deficient, while an extract of another gynecological sarcoma cell line not exhibiting microsatellite instability was repair proficient. The repair deficiency was complemented by a colon tumor cell extract that was defective in the hMLH1 protein but not by an extract defective in hMSH2 protein. This suggested that the defect in the uterine sarcoma line could be in hMSH2. Subsequent analysis of the gene revealed a 2-bp deletion in exon 14, leading to premature truncation of the hMSH2 protein at codon 796 and no detectable wild-type gene present. These data suggest that the microsatellite instability observed in these cell lines, and possibly in a significant number of gynecological sarcomas, is due to defective postreplication mismatch repair. There was no apparent correlation with microsatellite instability and clinical outcome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585651

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Different characteristics of mitochondrial microsatellite instability between uterine leiomyomas and leiomyosarcomas.

Authors:  Jae-Ho Lee; Tae-Yung Ryu; Chi-Heum Cho; Dae-Kwang Kim
Journal:  Pathol Oncol Res       Date:  2010-09-18       Impact factor: 3.201

2.  Functional overlap in mismatch repair by human MSH3 and MSH6.

Authors:  A Umar; J I Risinger; W E Glaab; K R Tindall; J C Barrett; T A Kunkel
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

3.  A variant of DNA polymerase beta acts as a dominant negative mutant.

Authors:  N Bhattacharyya; S Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Microsatellite instability in sarcomas.

Authors:  S S Martin; W G Hurt; L K Hedges; M G Butler; H S Schwartz
Journal:  Ann Surg Oncol       Date:  1998-06       Impact factor: 5.344

5.  Primary renal leiomyosarcoma with a tumor thrombus in the inferior vena cava.

Authors:  Mikio Konno; Takahiro Osawa; Kiyohiko Hotta; Ai Shimizu; Takashige Abe; Ryuji Matsumoto; Hiroshi Kikuchi; Nobuo Shinohara
Journal:  IJU Case Rep       Date:  2021-11-19

6.  Case Report: Complete Response to Antiangiogenesis and Immune Checkpoint Blockade in an Unresectable MMR-Deficient Leiomyosarcoma Harboring Biallelic Loss of PTEN.

Authors:  Xi Guo; Suyao Li; Hanxing Tong; Yong Zhang; Yuan Ji; Rongyuan Zhuang; Chenlu Zhang; Yang You; Weiqi Lu; Yuhong Zhou
Journal:  Front Oncol       Date:  2022-02-14       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.